Navigation Links
Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway

and markets one of the broadest portfolios of injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life-threatening diseases. The first FDA approved product to use this nab platform, ABRAXANE(R), was launched in 2005 for the treatment of metastatic breast cancer. Abraxis trades on The Nasdaq Global Market under the symbol ABBI. For more information about the company and its products, please visit www.abraxisbio.com.

FORWARD-LOOKING STATEMENT

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the timing and scope of clinical studies and trials for nab-rapamycin mTOR inhibitor (ABI 009), and nab-17AAG HSP90 inhibitor (ABI 010). Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward- looking statements. These factors include, without limitation, the fact that results from pre-clinical studies may not be predictive of results to be obtained in other pre-clinical studies or future clinical trials, delays in commencement and completion of clinical trials, including slower than anticipated patient enrollment and adverse events occurring during the clinical trials, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the availability and pricing of ingredients used in the manufacture of pharmaceutical products, the ability to successfully manufacture products in a time-sensitive and cost effective manner, the acceptance and demand of
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Abraxis BioScience Presents Pre-Clinical Findings That Support Role of SPARC Expression in Cancer and the Role of the Nanoparticle Albumin Bound (nab) Technology Platform in Targeting the Pathway
2. Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (Abraxane) with Anti-Angiogenic Agents to Increase Tumor Response
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
5. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
6. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
7. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
8. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
9. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
10. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
11. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
Post Your Comments:
(Date:3/26/2015)... OAK, Mich. , March 26, 2015 ... have performed the Midwest,s first commercial implant of ... Administration for patients with non-valvular atrial fibrillation. The Watchman ... long-term use of blood-thinning warfarin medication to reduce the ... most common heart rhythm disorder affecting more than 5 ...
(Date:3/26/2015)... , March 26, 2015 When ... by their existing PACS vendor their system would ... determined that they needed a better structured solution ... selected Avreo interWORKS due to its interface capabilities ... meaningful use standards through to the hospital,s radiology ...
(Date:3/26/2015)... DALLAS , March 26, 2015  CCS ... of home medical supplies for patients with chronic ... President and Chief Executive Officer, effective March 23.  ... second-largest telehealth company, where he was President of ... Carson was President and Executive Vice President of ...
Breaking Medicine Technology:Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2CCS Medical Team Hires Industry Operator Rodney Carson as CEO 2
... Calif., Aug. 31 Accuray Incorporated (Nasdaq: ARAY ... today financial results for the fourth quarter and fiscal year ... fourth quarter of fiscal 2010, Accuray reported total revenue of ... of fiscal 2009 total revenue of $58.8 million. For the ...
... 31 Reportlinker.com announces that a new market research report is ... the Coronary Stent Market http://www.reportlinker.com/p0203108/All-Change-in-the-Coronary-Stent-Market.html ... the prospects for key stent sectors Evaluate how ... and split in major regions and technology sectors ...
Cached Medicine Technology:Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 2Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 3Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 4Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 5Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 6Reportlinker Adds All Change in the Coronary Stent Market 2Reportlinker Adds All Change in the Coronary Stent Market 3Reportlinker Adds All Change in the Coronary Stent Market 4Reportlinker Adds All Change in the Coronary Stent Market 5Reportlinker Adds All Change in the Coronary Stent Market 6Reportlinker Adds All Change in the Coronary Stent Market 7Reportlinker Adds All Change in the Coronary Stent Market 8Reportlinker Adds All Change in the Coronary Stent Market 9
(Date:3/27/2015)... (PRWEB) March 27, 2015 Smile Brands ... providers of business support services to dental groups in ... an affiliated Castle Dental office in Hendersonville, ... Hendersonville, TN 37075, this new Castle Dental office provides ... receive the latest in comprehensive, quality dental care. Hendersonville ...
(Date:3/27/2015)... March 27, 2015 In light of ... number 1:15-cv-10429, U.S. District Court, District of Massachusetts; and ... Eastern District of Pennsylvania), the San Diego personal injury ... A.P.C. are announcing that they are available to investigate ... women who were prescribed Zofran while pregnant and who ...
(Date:3/26/2015)... Dr. Rod J. Rohrich, who served ... and has trained over 6500 surgeons through these ... based medicine (EBM), that is, the optimization of decision ... "We often hear from rhinoplasty surgeons who ... certainly not trying to stifle these discussions, we do ...
(Date:3/26/2015)... Florida Hospital teamed up with ABC Action ... campaign and live Dr. Oz event, which took place at ... than a thousand people came out to see Dr. Mehmet ... The world renowned cardiothoracic surgeon and Emmy award winning talk ... a panel of experts for the live health expo. Florida ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Behavioral ... consulting firm, announced the release of BathroomMap® , ... to increase access to public restrooms for travelers, especially ... bathroom apps, BathroomMap does not facilitate a paid, social ... to identify and rate local establishments that have clean, ...
Breaking Medicine News(10 mins):Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 3Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3
... on genetic puzzle to try to save the mammals , ... better understanding of an outbreak of cancerous tumors that is ... report. , Devil facial tumor disease, a kind of cancer ... physical contact, is one of only two types of cancer ...
... unavoidable, expert says , THURSDAY, Dec. 31 (HealthDay News) -- ... among the elderly. , The notion is drawn from a ... the activities of over 1,000 physically active men and women ... , Those who spent time volunteering were less likely to ...
... ... Marketing. We,ve seen a restaurant chain launched promotion that sold out in 90 minutes using ... ... of 2009 and closed, there were a handful that took the path less beaten and ...
... , WARMINSTER, Pa., Dec. 31 ... company, reports brisk sales for its recently launched, New Year,s ... for home gardeners who want to make New Year,s resolutions and ... giant seedpack contains varieties of vegetables and flowers to help lose ...
... , , WASHINGTON, Dec. 31 ... Campaign for Tobacco-Free Kids: , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ... historic step for health when it becomes the first major ... all restaurants and bars. This new law will protect ...
... with not just more but sicker residents, , THURSDAY, Dec. ... say the nation,s health-care system is not prepared to deal ... the 78-million-strong baby-boom generation are about to turn 65. And ... older than 65 will double, according to a report on ...
Cached Medicine News:Health News:Clues to Cancer That Could Wipe Out Tasmanian Devils 2Health News:Volunteering May Keep Elderly Stronger 2Health News:Volunteering May Keep Elderly Stronger 3Health News:Small Businesses In Singapore Outmarkets & Outperforms Bigger Players in Tough Economy With Online Marketing 2Health News:New Year's Resolution Garden Growing Sales for Burpee 2Health News:North Carolina Goes Smoke-Free on Jan. 2 in Historic Step for Health 2Health News:North Carolina Goes Smoke-Free on Jan. 2 in Historic Step for Health 3Health News:As U.S. Ages, Health Care May Need to Change 2Health News:As U.S. Ages, Health Care May Need to Change 3
The XT-2000i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...
The SE-9000 automated hematology analyzer provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
Ac.T 5diff CP allows quick and direct access to a closed sample tubea feature that reduces manual sample handling, saves time and enhances safety by eliminating operators exposure to biohazards....
The XE-2100 automated hematology analyzer features new hematology parameters as NRBC, IRF, and HPC that offer valuable and accurate clinical information....
Medicine Products: